Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection
David G. Brooks, … , Dorian B. McGavern, Michael B.A. Oldstone
David G. Brooks, … , Dorian B. McGavern, Michael B.A. Oldstone
Published June 1, 2006
Citation Information: J Clin Invest. 2006;116(6):1675-1685. https://doi.org/10.1172/JCI26856.
View: Text | PDF
Research Article Virology

Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection

  • Text
  • PDF
Abstract

Failure to clear persistent viral infections results from the early loss of T cell activity. A pertinent question is whether the immune response is programmed to fail or if nonresponsive T cells can specifically be fixed to eliminate infection. Although evidence indicates that T cell expansion is permanently programmed during the initial priming events, the mechanisms that determine the acquisition of T cell function are less clear. Herein we show that in contrast to expansion, the functional programming of T cell effector and memory responses in vivo in mice is not hardwired during priming but is alterable and responsive to continuous instruction from the antigenic environment. As a direct consequence, dysfunctional T cells can be functionally reactivated during persistent infection even after an initial program of inactivation has been instituted. We also show that early therapeutic reductions in viral replication facilitate the preservation of antiviral CD4+ T cell activity, enabling the long-term control of viral replication. Thus, dysfunctional antiviral T cells can regain activity, providing a basis for future therapeutic strategies to treat persistent viral infections.

Authors

David G. Brooks, Dorian B. McGavern, Michael B.A. Oldstone

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2006 Total
Citations: 2 1 6 5 4 8 4 3 6 4 8 3 2 5 4 9 1 3 1 79
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (79)

Title and authors Publication Year
T Cell Exhaustion in Allergic Diseases and Allergen Immunotherapy: A Novel Biomarker?
Xu Q, Li L, Zhu R
Current allergy and asthma reports 2025
Lymph node macrophages drive immune tolerance and resistance to cancer therapy by induction of the immune-regulatory cytokine IL-33
Lamorte S, Quevedo R, Jin R, Neufeld L, Liu ZQ, Ciudad MT, Lukhele S, Bruce J, Mishra S, Zhang X, Saeed ZK, Berman H, Philpott DJ, Girardin SE, Harding S, Munn DH, Mak TW, Karlsson MC, Brooks DG, McGaha TL
Cancer cell 2025
IL-27 expression regulation and its effects on adaptive immunity against viruses
Andres-Martin F, James C, Catalfamo M
Frontiers in immunology 2024
Long-term persistence and functionality of adoptively transferred antigen-specific T cells with genetically ablated PD-1 expression.
Dötsch S, Svec M, Schober K, Hammel M, Wanisch A, Gökmen F, Jarosch S, Warmuth L, Barton J, Cicin-Sain L, D'Ippolito E, Busch DH
Proceedings of the National Academy of Sciences 2023
The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer
Zhang J, Lei F, Tan H
Frontiers in immunology 2023
Regulation of CD8(+) T memory and exhaustion by the mTOR signals.
Chen Y, Xu Z, Sun H, Ouyang X, Han Y, Yu H, Wu N, Xie Y, Su B
Cellular & molecular immunology 2023
Let-7 enhances murine anti-tumor CD8 T cell responses by promoting memory and antagonizing terminal differentiation.
Wells AC, Hioki KA, Angelou CC, Lynch AC, Liang X, Ryan DJ, Thesmar I, Zhanybekova S, Zuklys S, Ullom J, Cheong A, Mager J, Hollander GA, Pobezinskaya EL, Pobezinsky LA
Nature Communications 2023
Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor control
Guo M, Abd-Rabbo D, Bertol BC, Carew M, Lukhele S, Snell LM, Xu W, Boukhaled GM, Elsaesser H, Halaby MJ, Hirano N, McGaha TL, Brooks DG
Cell Reports 2023
Possibility of PD-1/PD-L1 Inhibitors for the Treatment of Patients with Chronic Hepatitis B Infection
Su M, Ye T, Wu W, Shu Z, Xia Q
Digestive diseases (Basel, Switzerland) 2023
Knowns and Unknowns about CAR-T Cell Dysfunction
A Titov, Y Kaminskiy, I Ganeeva, E Zmievskaya, A Valiullina, A Rakhmatullina, A Petukhov, R Miftakhova, A Rizvanov, E Bulatov
Cancers 2022
The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme
Daei Sorkhabi A, Sarkesh A, Saeedi H, Marofi F, Ghaebi M, Silvestris N, Baradaran B, Brunetti O
Frontiers in Oncology 2022
Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities
Nova Z, Zemanek T, Botek N
International journal of molecular sciences 2022
The transcription factor IRF2 drives interferon-mediated CD8+ T cell exhaustion to restrict anti-tumor immunity
Lukhele S, Abd Rabbo D, Guo M, Shen J, Elsaesser HJ, Quevedo R, Carew M, Gadalla R, Snell LM, Mahesh L, Ciudad MT, Snow BE, You-Ten A, Haight J, Wakeham A, Ohashi PS, Mak TW, Cui W, McGaha TL, Brooks DG
Immunity 2022
Population dynamics and gene regulation of T cells in response to chronic antigen stimulation
Hsiung S, Egawa T
International Immunology 2022
PDL1‐positive exosomes suppress antitumor immunity by inducing tumor‐specific CD8 + T cell exhaustion during metastasis
J Chen, Y Song, F Miao, G Chen, Y Zhu, N Wu, L Pang, Z Chen, X Chen
Cancer Science 2021
Prevention of CD8 T Cell Deletion during Chronic Viral Infection
DG Brooks, A Tishon, MB Oldstone, DB McGavern
Viruses 2021
Hepatitis B Virus Reactivation in Cancer Patients Treated With Immune Checkpoint Inhibitors
EA Burns, IN Muhsen, K Anand, J Xu, G Umoru, AN Arain, M Abdelrahim
Journal of immunotherapy (Hagerstown, Md. : 1997) 2021
Dynamic CD4+ T cell heterogeneity defines subset-specific suppression and PD-L1-blockade-driven functional restoration in chronic infection
LM Snell, W Xu, D Abd-Rabbo, G Boukhaled, M Guo, BL Macleod, HJ Elsaesser, K Hezaveh, N Alsahafi, S Lukhele, S Nejat, R Prabhakaran, S Epelman, TL McGaha, DG Brooks
Nature Immunology 2021
Muscle-Directed Delivery of an AAV1 Vector Leads to Capsid-Specific T Cell Exhaustion in Nonhuman Primates and Humans
G Gernoux, AM Gruntman, M Blackwood, M Zieger, TR Flotte, C Mueller
Molecular Therapy 2020
Cellular and Molecular Mechanisms of CD8+ T Cell Differentiation, Dysfunction and Exhaustion
DJ Verdon, M Mulazzani, MR Jenkins
International journal of molecular sciences 2020
Lentiviral-Vector-Based Dendritic Cell Vaccine Synergizes with Checkpoint Blockade to Clear Chronic Viral Infection
TD Norton, T Tada, R Leibowitz, V van der Heide, D Homann, NR Landau
Molecular Therapy 2020
Revisiting T Cell Tolerance as a Checkpoint Target for Cancer Immunotherapy
S Nüssing, JA Trapani, IA Parish
Frontiers in immunology 2020
A network of immune and microbial modifications underlies viral persistence in the gastrointestinal tract
BL Macleod, HJ Elsaesser, LM Snell, RJ Dickson, M Guo, K Hezaveh, W Xu, A Kothari, TL McGaha, CJ Guidos, DG Brooks
Journal of Experimental Medicine 2020
The repertoire of tumor-infiltrating lymphocytes within the microenvironment of oral squamous cell carcinoma reveals immune dysfunction
H Quan, Z Shan, Z Liu, S Liu, L Yang, X Fang, K Li, B Wang, Z Deng, Y Hu, Z Yao, J Huang, J Yu, K Xia, Z Tang, L Fang
Cancer Immunology, Immunotherapy 2020
Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells
D Wijewarnasuriya, C Bebernitz, AV Lopez, S Rafiq, RJ Brentjens
Cancer immunology research 2020
Chronic virus infection drives CD8 T cell-mediated thymic destruction and impaired negative selection
HJ Elsaesser, M Mohtashami, I Osokine, LM Snell, CR Cunningham, GM Boukhaled, DB McGavern, JC Zúñiga-Pflücker, DG Brooks
Proceedings of the National Academy of Sciences 2020
HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules
C Ackermann, M Smits, R Woost, JM Eberhard, S Peine, S Kummer, M Marget, T Kuntzen, WW Kwok, AW Lohse, T Jacobs, T Boettler, JS zur Wiesch
Scientific Reports 2019
Striking a Balance—Cellular and Molecular Drivers of Memory T Cell Development and Responses to Chronic Stimulation
JL Hope, CJ Stairiker, EA Bae, DC Otero, LM Bradley
Frontiers in immunology 2019
The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance
G Schönrich, MJ Raftery
Frontiers in Cellular and Infection Microbiology 2019
Can Immunogenic Chemotherapies Relieve Cancer Cell Resistance to Immune Checkpoint Inhibitors?
TR Vargas, L Apetoh
Frontiers in immunology 2019
CD8+ T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity
LM Snell, BL MacLeod, JC Law, I Osokine, HJ Elsaesser, K Hezaveh, RJ Dickson, MA Gavin, CJ Guidos, TL McGaha, DG Brooks
Immunity 2018
Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management
AJ Czaja
Digestive Diseases and Sciences 2018
Prophylactic and therapeutic approaches for human metapneumovirus
P Kumar, M Srivastava
VirusDisease 2018
T cell exhaustion: from pathophysiological basics to tumor immunotherapy
K Catakovic, E Klieser, D Neureiter, R Geisberger
Cell Communication and Signaling 2017
TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia
K Catakovic, FJ Gassner, C Ratswohl, N Zaborsky, S Rebhandl, M Schubert, M Steiner, JC Gutjahr, L Pleyer, A Egle, TN Hartmann, R Greil, R Geisberger
OncoImmunology 2017
Extrinsic Protein Tyrosine Phosphatase Non-Receptor 22 Signals Contribute to CD8 T Cell Exhaustion and Promote Persistence of Chronic Lymphocytic Choriomeningitis Virus Infection
T Jofra, G Galvani, M Kuka, RD Fonte, BG Mfarrej, M Iannacone, S Salek-Ardakani, M Battaglia, G Fousteri
Frontiers in immunology 2017
Varicella-Zoster Virus–Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults
A Weinberg, J Canniff, N Rouphael, A Mehta, M Mulligan, JA Whitaker, MJ Levin
Journal of immunology (Baltimore, Md. : 1950) 2017
Purging Exhausted Virus-Specific CD8 T Cell Phenotypes by Somatic Cell Reprogramming
J Chan, PY Kim, E Kranz, Y Nagaoka, YJ Lee, J Wen, HJ Elsaesser, M Qin, DG Brooks, GE Ringpis, IS Chen, M Kamata
AIDS Research and Human Retroviruses 2017
TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearance
Y Yang, ME Kohler, CD Chien, CT Sauter, E Jacoby, C Yan, Y Hu, K Wanhainen, H Qin, TJ Fry
Science Translational Medicine 2017
Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8+ T Cell Exhaustion
B Bengsch, AL Johnson, M Kurachi, PM Odorizzi, KE Pauken, J Attanasio, E Stelekati, LM McLane, MA Paley, GM Delgoffe, EJ Wherry
Immunity 2016
Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion
E Ahn, B Youngblood, J Lee, J Lee, S Sarkar, R Ahmed, MS Diamond
Journal of virology 2016
Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence
CR Cunningham, A Champhekar, MV Tullius, BJ Dillon, A Zhen, JR de la Fuente, J Herskovitz, H Elsaesser, LM Snell, EB Wilson, JC de la Torre, SG Kitchen, MA Horwitz, SJ Bensinger, ST Smale, DG Brooks, P Loke
PLoS pathogens 2016
Exploitation of Interleukin-10 (IL-10) Signaling Pathways: Alternate Roles of Viral and Cellular IL-10 in Rhesus Cytomegalovirus Infection
MK Eberhardt, A Deshpande, J Fike, R Short, KA Schmidt, SA Blozis, MR Walter, PA Barry, JU Jung
Journal of virology 2016
A Critical Role of IL-21-Induced BATF in Sustaining CD8-T-Cell-Mediated Chronic Viral Control
G Xin, DM Schauder, B Lainez, JS Weinstein, Z Dai, Y Chen, E Esplugues, R Wen, D Wang, IA Parish, AJ Zajac, J Craft, W Cui
Cell Reports 2015
Protective Efficacy of Individual CD8+ T Cell Specificities in Chronic Viral Infection
S Johnson, A Bergthaler, F Graw, L Flatz, WV Bonilla, CA Siegrist, PH Lambert, RR Regoes, DD Pinschewer
Journal of immunology (Baltimore, Md. : 1950) 2015
A Jekyll and Hyde Profile: Type 1 Interferon Signaling Plays a Prominent Role in the Initiation and Maintenance of a Persistent Virus Infection
MB Oldstone
The Journal of Infectious Diseases 2015
Molecular and cellular insights into T cell exhaustion
EJ Wherry, M Kurachi
Nature Reviews Immunology 2015
Innate and Adaptive Immune Regulation During Chronic Viral Infections
EI Zuniga, M Macal, GM Lewis, JA Harker
Annual Review of Virology 2015
T cell exhaustion during persistent viral infections
SM Kahan, EJ Wherry, AJ Zajac
Virology 2015
Advanced Molecular Surveillance of Hepatitis C Virus
L Rossi, A Escobar-Gutierrez, P Rahal
Viruses 2015
IRF4 Regulates the Ratio of T-Bet to Eomesodermin in CD8+ T Cells Responding to Persistent LCMV Infection
R Nayar, E Schutten, S Jangalwe, PA Durost, LL Kenney, JM Conley, K Daniels, MA Brehm, RM Welsh, LJ Berg, J Sun
PloS one 2015
Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection
I Osokine, LM Snell, CR Cunningham, DH Yamada, EB Wilson, HJ Elsaesser, JC de la Torre, D Brooks
Proceedings of the National Academy of Sciences 2014
Distinctive features of CD4+ T cell dysfunction in chronic viral infections:
A Morou, BE Palmer, DE Kaufmann
Current Opinion in HIV and AIDS 2014
The Transcription Factor FoxO1 Sustains Expression of the Inhibitory Receptor PD-1 and Survival of Antiviral CD8+ T Cells during Chronic Infection
MM Staron, SM Gray, HD Marshall, IA Parish, JH Chen, CJ Perry, G Cui, MO Li, SM Kaech
Immunity 2014
Networking at the Level of Host Immunity: Immune Cell Interactions during Persistent Viral Infections
CT Ng, LM Snell, DG Brooks, MB Oldstone
Cell Host & Microbe 2013
PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis
BH Zinselmeyer, S Heydari, C Sacristan, D Nayak, M Cammer, J Herz, X Cheng, SJ Davis, ML Dustin, DB McGavern
Journal of Experimental Medicine 2013
Emergence of Distinct Multiarmed Immunoregulatory Antigen-Presenting Cells during Persistent Viral Infection
EB Wilson, Y Kidani, H Elsaesser, J Barnard, L Raff, CL Karp, S Bensinger, DG Brooks
Cell Host & Microbe 2012
Network Analysis Reveals Centrally Connected Genes and Pathways Involved in CD8+ T Cell Exhaustion versus Memory
TA Doering, A Crawford, JM Angelosanto, MA Paley, CG Ziegler, EJ Wherry
Immunity 2012
T-cell exhaustion due to persistent antigen: quantity not quality?
EI Zuniga, JA Harker
European Journal of Immunology 2012
Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection
JM Angelosanto, SD Blackburn, A Crawford, EJ Wherry
Journal of virology 2012
Homeostatic Division Is Not Necessary for Antigen-Specific CD4 + Memory T Cell Persistence
E Corbo-Rodgers, KR Wiehagen, ES Staub, JS Maltzman
Journal of immunology (Baltimore, Md. : 1950) 2012
Induction and function of virus-specific CD4+ T cell responses
JK Whitmire
Virology 2011
Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells
LM Fahey, EB Wilson, H Elsaesser, CD Fistonich, DB McGavern, DG Brooks
Journal of Experimental Medicine 2011
Dynamics of Regulatory T-Cells during Pregnancy: Effect of HIV Infection and Correlations with Other Immune Parameters
K Richardson, A Weinberg
PloS one 2011
Update on HCV-specific immunity
D Ciuffreda, AY Kim
Current Opinion in HIV and AIDS 2011
HIV and Interleukin-10 induced aberrant deletion of Dendritic cells by Natural Killer cells
Galit Alter, Daniel Kavanagh, Suzannah Rihn, Rutger Luteijn, David Brooks, Michael B.A. Oldstone, Jan van Lunzen, Marcus Altfeld
Journal of Clinical Investigation 2010
Suppression and Regulation of Immune Responses
MC Cuturi, I Anegon
Suppression and Regulation of Immune Responses 2010
Negative Co-Receptors and Ligands
R Ahmed, T Honjo
2010
IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection
DG Brooks, KB Walsh, H Elsaesser, MB Oldstone
Proceedings of the National Academy of Sciences 2010
Regulatory function of cytomegalovirus-specific CD4+CD27-CD28- T cells
A Tovar-Salazar, J Patterson-Bartlett, R Jesser, A Weinberg
Virology 2010
T-cell exhaustion: characteristics, causes and conversion
JS Yi, MA Cox, AJ Zajac
Immunology 2010
Opposing positive and negative regulation of T cell activity during viral persistence
LM Fahey, DG Brooks
Current Opinion in Immunology 2010
Translating insights from persistent LCMV infection into anti-HIV immunity
EB Wilson, DG Brooks
Immunologic Research 2010
Pronounced Virus-Dependent Activation Drives Exhaustion but Sustains IFN-γ Transcript Levels
KJ Mackerness, MA Cox, LM Lilly, CT Weaver, LE Harrington, AJ Zajac
Journal of immunology (Baltimore, Md. : 1950) 2010
Chronic Antigen Stimulation Alone Is Sufficient to Drive CD8 + T Cell Exhaustion
CM Bucks, JA Norton, AC Boesteanu, YM Mueller, PD Katsikis
Journal of immunology (Baltimore, Md. : 1950) 2009
IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection
DG Brooks, AM Lee, H Elsaesser, DB McGavern, MB Oldstone
Journal of Experimental Medicine 2008
IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection
DG Brooks, SJ Ha, H Elsaesser, AH Sharpe, GJ Freeman, MB Oldstone
Proceedings of the National Academy of Sciences 2008
Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection
SJ Ha, SN Mueller, EJ Wherry, DL Barber, RD Aubert, AH Sharpe, GJ Freeman, R Ahmed
Journal of Experimental Medicine 2008
Interleukin-10 determines viral clearance or persistence in vivo
DG Brooks, MJ Trifilo, KH Edelmann, L Teyton, DB McGavern, MB Oldstone
Nature Medicine 2006

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts